Find out about our current, on-going, urology research trials

Urology

Trial: MRI guided HIFU for the treatment of prostate cancer

Research area

Radiology and urology

Summary

This study is looking to prove that MRI guided high intensity focussed ultrasound (HIFU), a technique used to destroy tumours, is a safe and effective treatment for prostate cancer.
The technique uses MRI to help guide the surgeon to the exact location of the tumour. Once located, intense heat from the ultrasound waves is applied directly to the tumour to destroy it.

Unlike current HIFU treatments, clinicians are able to see the tumour in real-time and monitor the treatment as they go along. This ensures that only cancerous tissue is destroyed and not healthy tissue. This means patients are far less likely to be left with the side effects associated with other treatments and do not have to undergo an invasive operation.

Who can take part?

Suitable for male patients of any age who have had a diagnosis of prostate cancer PSA <15, visible unilateral lesion and T2 on MRI

Study location

Charing Cross Hospital and St Mary’s Hospital

Time commitment

1 day for screening and 1 day for treatment

Overnight stay required?

1 day

Contact 

Mathias Winkler, CoPI
Email: imperial.pca006@nhs.net.